Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme

Wim van den Brink, John Strang, Antoni Gual, Per Sørensen, Thomas Jon Jensen, Karl Mann

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science